Comparison of the Predictive Power of a Combination versus Individual Biomarker Testing in Non–Small Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors

PURPOSE: Since tumor mutational burden (TMB) and gene expression profiling (GEP) have complementary effects, they may have improved predictive power when used in combination. Here, we investigated the ability of TMB and GEP to predict the immunotherapy response in patients with non–small cell lung c...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Hyojin, Kwon, Hyun Jung, Kim, Eun Sun, Kwon, Soohyeon, Suh, Kyoung Jin, Kim, Se Hyun, Kim, Yu Jung, Lee, Jong Seok, Chung, Jin-Haeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9016300/
https://www.ncbi.nlm.nih.gov/pubmed/34237208
http://dx.doi.org/10.4143/crt.2021.583

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9016300/
https://www.ncbi.nlm.nih.gov/pubmed/34237208
http://dx.doi.org/10.4143/crt.2021.583

Ejemplares similares